Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

CANC

Tema Oncology ETF

May 06 • 03:43PM ET

27.46

Dollar change -0.11
Percentage change -0.40	%

Financial • Exchange Traded Fund • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Category	Global or ExUS Equities - Industry Sector	Asset Type	Equities (Stocks)	Tags	Global	Return% 1Y	-	Shs Outstand		Perf Week	3.16%
Sponsor	Tema	ETF Type		Tags	equity	Return% 3Y	-	Total Holdings	48	Perf Month	1.59%
Fund Family		Bond Type		Tags	healthcare	Return% 5Y	-	AUM	18.72M	Perf Quarter	3.47%
Index	-	Average Maturity		Tags	-	Return% 10Y		NAV%		Perf Half Y	24.84%
Index Weighting		Commodity Type		Tags	-	Return% SI		NAV/sh		Perf Year	-
Active/Passive		Quant Type		Tags	-	Flows% 1M	0.00%	52W Range	21.46 - 29.16	Perf YTD	4.03%
Dividend TTM	0.13 (0.49%)	ESG Type		Tags	-	Flows% 3M	1.52%	52W High	-5.83%	Beta	-
Dividend Ex-Date	Dec 13, 2023	Dividend Type		Sector/Theme		Flows% YTD	2.96%	52W Low	27.98%	ATR (14)	0.33
Expense	0.75%	Structure Type		Region		Flows% 1Y		RSI (14)	60.11	Volatility	0.74% 0.38%
Option/Short	No / Yes	Growth/Value		Dev/Emerg		Flows% 3Y		Rel Volume	0.46	Prev Close	27.57
Inverse/Leveraged		Market Cap		Currency		Flows% 5Y		Avg Volume	0.62K	Price	27.46
SMA20	4.38%	SMA50	0.90%	SMA200	7.97%	Trades		Volume	277	Change	-0.40%

Tema Oncology ETF seeks to provide long-term growth. Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.

open in yahoo | open in marketwatch | open in google

CANC

Tema Oncology ETF

Upgrade your FINVIZ experience